295 related articles for article (PubMed ID: 10712322)
1. Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis.
Schwartzman K; Menzies D
Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):780-9. PubMed ID: 10712322
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and cost effectiveness of screening immigrants schemes for tuberculosis (TB) on arrival from high TB endemic countries to low TB prevalent countries.
Sanneh AF; Al-Shareef AM
Afr Health Sci; 2014 Sep; 14(3):663-71. PubMed ID: 25352886
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations.
Dasgupta K; Schwartzman K; Marchand R; Tennenbaum TN; Brassard P; Menzies D
Am J Respir Crit Care Med; 2000 Dec; 162(6):2079-86. PubMed ID: 11112118
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of tuberculosis control strategies among immigrants and refugees.
Dasgupta K; Menzies D
Eur Respir J; 2005 Jun; 25(6):1107-16. PubMed ID: 15929967
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.
Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP
Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness.
Snyder DC; Paz EA; Mohle-Boetani JC; Fallstad R; Black RL; Chin DP
Am J Respir Crit Care Med; 1999 Jul; 160(1):178-85. PubMed ID: 10390397
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.
Oxlade O; Schwartzman K; Menzies D
Int J Tuberc Lung Dis; 2007 Jan; 11(1):16-26. PubMed ID: 17217125
[TBL] [Abstract][Full Text] [Related]
8. Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis.
Pareek M; Bond M; Shorey J; Seneviratne S; Guy M; White P; Lalvani A; Kon OM
Thorax; 2013 Mar; 68(3):230-9. PubMed ID: 22693179
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis screening for long-term care: a cost-effectiveness analysis.
Verma G; Chuck AW; Jacobs P
Int J Tuberc Lung Dis; 2013 Sep; 17(9):1170-7. PubMed ID: 23928166
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis screening of travelers to higher-incidence countries: a cost-effectiveness analysis.
Tan M; Menzies D; Schwartzman K
BMC Public Health; 2008 Jun; 8():201. PubMed ID: 18534007
[TBL] [Abstract][Full Text] [Related]
11. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a school-based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country.
Brassard P; Steensma C; Cadieux L; Lands LC
Pediatrics; 2006 Feb; 117(2):e148-56. PubMed ID: 16452324
[TBL] [Abstract][Full Text] [Related]
13. Cost-utility of tuberculosis prevention among HIV-infected adults in Kampala, Uganda.
Shrestha RK; Mugisha B; Bunnell R; Mermin J; Odeke R; Madra P; Hitimana-Lukanika C; Adatu-Engwau F; Blandford JM
Int J Tuberc Lung Dis; 2007 Jul; 11(7):747-54. PubMed ID: 17609049
[TBL] [Abstract][Full Text] [Related]
14. The outcome of a cohort of tuberculin-positive predominantly South Asian new entrants aged 16-34 to the UK: Blackburn 1989-2001.
Choudhury IW; West CR; Ormerod LP
J Public Health (Oxf); 2014 Sep; 36(3):390-5. PubMed ID: 24277780
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of including tuberculin skin testing in an IPT program for HIV-infected persons in Uganda.
Shrestha RK; Mugisha B; Bunnell R; Mermin J; Hitimana-Lukanika C; Odeke R; Madra P; Adatu F; Blandford JM
Int J Tuberc Lung Dis; 2006 Jun; 10(6):656-62. PubMed ID: 16776453
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
Flaherman VJ; Porco TC; Marseille E; Royce SE
Pediatrics; 2007 Jul; 120(1):90-9. PubMed ID: 17606566
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of pulmonary tuberculosis using different methods in group screenings.
Beser E
East Afr Med J; 1993 Dec; 70(12):768-71. PubMed ID: 8026349
[TBL] [Abstract][Full Text] [Related]
18. Public health interventions to encourage TB class A/B1/B2 immigrants to present for TB screening.
Catlos EK; Cantwell MF; Bhatia G; Gedin S; Lewis J; Mohle-Boetani JC
Am J Respir Crit Care Med; 1998 Oct; 158(4):1037-41. PubMed ID: 9769257
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis.
Diel R; Wrighton-Smith P; Zellweger JP
Eur Respir J; 2007 Aug; 30(2):321-32. PubMed ID: 17504793
[TBL] [Abstract][Full Text] [Related]
20. Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.
Nuwaha F
East Afr Med J; 1998 Sep; 75(9):520-7. PubMed ID: 10493054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
